NCODA recently announced a collaboration with the American Society of Clinical Oncology (ASCO) to develop oral oncology dispensing standards that will enhance ASCO’s Quality Oncology Practice Initiative (QOPI) Certification Program. Stephen Grubbs, MD, FASCO, VP of Clinical Affairs for ASCO, explained the details of this effort in his keynote address.
The QOPI quality program seeks to foster a culture of self-improvement for practices and offers more than 150 evidence-based quality measures for evaluation. Participating practices receive both individual performance scores and benchmarked scores aggregated from all participants, which identify areas of improvement and offer guidance on developing and implementing initiatives to improve outcomes and deliver better patient care.
While separate from ACHC or URAC accreditation, QOPI certification is another significant proof point for practices to demonstrate the quality of care they provide, and the work applied toward this certification can be applied to several other valuable programs. QOPI-certified practices may qualify for Improvement Activity points that count toward Merit-based Incentive Payment System (MIPS) reporting. It can also help practices gain more leverage with payers and be used to help obtain Joint Commission accreditation for hospital-based practices or a “Center of Excellence” designation from the National Comprehensive Cancer Network (NCCN).
Currently, QOPI standards are somewhat labor intensive. In partnering together, ASCO and NCODA will work with a multidisciplinary committee to determine which standards are necessary and home in on the standards that truly demonstrate quality. Additionally, medically-integrated dispensing will be added on to the current QOPI certification, and standards for patient education and adherence will be expanded. A formal launch of the updated QOPI standards is slated for the next ASCO Annual Meeting in June 2020.